Illinois 2023-2024 Regular Session

Illinois House Bill HB2631 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB2631 Introduced , by Rep. Marcus C. Evans, Jr. SYNOPSIS AS INTRODUCED: 305 ILCS 5/5-5.12f new Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that for the purpose of removing barriers to the timely and equitable treatment of hepatitis C, prior authorization mandates and utilization management controls shall not be imposed under the fee-for-service and managed care medical assistance programs on any FDA-approved direct-acting antivirals for the treatment of hepatitis C that are listed as preferred on the Illinois Medicaid Preferred Drug List. LRB103 26141 KTG 52498 b A BILL FOR 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB2631 Introduced , by Rep. Marcus C. Evans, Jr. SYNOPSIS AS INTRODUCED: 305 ILCS 5/5-5.12f new 305 ILCS 5/5-5.12f new Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that for the purpose of removing barriers to the timely and equitable treatment of hepatitis C, prior authorization mandates and utilization management controls shall not be imposed under the fee-for-service and managed care medical assistance programs on any FDA-approved direct-acting antivirals for the treatment of hepatitis C that are listed as preferred on the Illinois Medicaid Preferred Drug List. LRB103 26141 KTG 52498 b LRB103 26141 KTG 52498 b A BILL FOR
2	2	103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB2631 Introduced , by Rep. Marcus C. Evans, Jr. SYNOPSIS AS INTRODUCED:
3	3	305 ILCS 5/5-5.12f new 305 ILCS 5/5-5.12f new
4	4	305 ILCS 5/5-5.12f new
5	5	Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that for the purpose of removing barriers to the timely and equitable treatment of hepatitis C, prior authorization mandates and utilization management controls shall not be imposed under the fee-for-service and managed care medical assistance programs on any FDA-approved direct-acting antivirals for the treatment of hepatitis C that are listed as preferred on the Illinois Medicaid Preferred Drug List.
6	6	LRB103 26141 KTG 52498 b LRB103 26141 KTG 52498 b
7	7	LRB103 26141 KTG 52498 b
8	8	A BILL FOR
9	9	HB2631LRB103 26141 KTG 52498 b HB2631 LRB103 26141 KTG 52498 b
10	10	HB2631 LRB103 26141 KTG 52498 b
11	11	1 AN ACT concerning public aid.
12	12	2 Be it enacted by the People of the State of Illinois,
13	13	3 represented in the General Assembly:
14	14	4 Section 5. The Illinois Public Aid Code is amended by
15	15	5 adding Section 5-5.12f as follows:
16	16	6 (305 ILCS 5/5-5.12f new)
17	17	7 Sec. 5-5.12f. Prescription drugs for hepatitis C virus; no
18	18	8 prior approval mandates or utilization management controls.
19	19	9 Notwithstanding any other provision of this Code to the
20	20	10 contrary, for the purpose of removing barriers to the timely
21	21	11 and equitable treatment of hepatitis C, prior authorization
22	22	12 mandates and utilization management controls shall not be
23	23	13 imposed under the fee-for-service and managed care medical
24	24	14 assistance programs on any FDA-approved direct-acting
25	25	15 antivirals for the treatment of hepatitis C that are listed as
26	26	16 preferred on the Illinois Medicaid Preferred Drug List.
27	27
28	28
29	29
30	30	103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB2631 Introduced , by Rep. Marcus C. Evans, Jr. SYNOPSIS AS INTRODUCED:
31	31	305 ILCS 5/5-5.12f new 305 ILCS 5/5-5.12f new
32	32	305 ILCS 5/5-5.12f new
33	33	Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that for the purpose of removing barriers to the timely and equitable treatment of hepatitis C, prior authorization mandates and utilization management controls shall not be imposed under the fee-for-service and managed care medical assistance programs on any FDA-approved direct-acting antivirals for the treatment of hepatitis C that are listed as preferred on the Illinois Medicaid Preferred Drug List.
34	34	LRB103 26141 KTG 52498 b LRB103 26141 KTG 52498 b
35	35	LRB103 26141 KTG 52498 b
36	36	A BILL FOR
37	37
38	38
39	39
40	40
41	41
42	42	305 ILCS 5/5-5.12f new
43	43
44	44
45	45
46	46	LRB103 26141 KTG 52498 b
47	47
48	48
49	49
50	50
51	51
52	52
53	53
54	54
55	55
56	56	HB2631 LRB103 26141 KTG 52498 b